Pharmacies of all sizes enjoy the safety benefits provided by CSTD use during the drug preparation process, and user satisfaction rates remain high. As this product class nears ubiquitous adoption, solid product loyalty across the marketplace indicates there are a variety of quality options available for those few facilities yet to adopt this technology.
While the adoption rate for CSTDs use in the pharmacy is an impressive 92%, there was no forward progress this year in converting those final facilities to provide this key safety tool to their staff.
CSTD use during compounding is common practice across facilities of all sizes.
CSTD vendors receive high user satisfaction rates, with 86% of users giving top marks to their devices.
BD, Equashield, and ICU Medical are the leading vendors in the CSTD marketplace.
The leading CSTD devices in use are Equashield, B. Braun’s OnGuard, and BD’s PhaSeal.
Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.